1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. FDA Discusses Registration and Listing Rules for LDTs

FDA Discusses Registration and Listing Rules for LDTs

Dec 10, 2024

On December 3, the FDA led a webinar reviewing compliance for its registration and device listing requirements for laboratory-developed tests (LDTs). These requirements are part of stage 2 of the FDA LDT oversight regulation and take effect May 2026. Stage 1 requirements take effect May 6, 2025.

The CAP had previously urged the FDA to provide more education about the agency’s process for registration and listing how the process would apply to LDTs.

Review the FDA webinar slides and webpage.

Most Recent Content

  1. November 4, 2025
    Advocacy Updates Advocacy Updates
    Nov 4, 2025
  2. Medical coalition urges Congress to pass RESULTS Act
    Advocacy Updates Advocacy Updates
    Nov 4, 2025
  3. Urgent call to halt CMS cuts by January
    Advocacy Updates Advocacy Updates
    Nov 4, 2025
  4. Members needed to tell Congress to protect patients; some will "fly-in" Wednesday
    Advocacy Updates Advocacy Updates
    Nov 4, 2025
  5. CAP to DHS: Pathologists, lab pros should be exempt from H-1B visa fee
    Advocacy Updates Advocacy Updates
    Nov 4, 2025
  6. View All
To Top